1Q Review: Subdued volumes; profitability improvement led by cost optimization; Stay Neutral on Ambuja, Sell on ACC

Research evidence excerpt

1Q Review: Subdued volumes; profitability improvement led by cost optimization; Stay Neutral on Ambuja, Sell on ACC

I”), authorised by the Prudential Regulation Authority (“PRA”) and regulated by the Financial Conduct Authority

(“FCA”) and the PRA, has approved this research in connection with its distribution in the United Kingdom.

European Economic Area: Goldman Sachs Bank Europe SE (“GSBE”) is a credit institution incorporated in Germany and, within the Single Supervisory

Mechanism, subject to direct prudential supervision by the European Central Bank and in other respects supervised by German Federal Financial

Supervisory Authority (Bundesanstalt für Finanzdienstleistungsaufsicht, BaFin) and Deutsche Bundesbank and disseminates research within the

European Economic Area.

General disclosures

This research is for our clients only. Other than disclosures relating to Goldman Sachs, this research is based on current public information that we

consider reliable, but we do not represent it is accurate or complete, and it should not be relied on as such. The information, opinions, estimates and

forecasts contained herein are as of the date hereof and are subject to change without prior notification. We seek to update our research as

appropriate, but various regulations may prevent us from doing so. Other than certain industry reports published on a periodic basis, the large majority

of reports are published at irregular intervals as appropriate in the analyst’s judgment.

Goldman Sachs conducts a global full-service, integrated investment banking, investment management, and brokerage business. We have investment

banking and other business relationships with a substantial percentage of the companies covered by Global Investment Research. Goldman Sachs & Co.